Search Results
Search for other papers by E Patterson in
Google Scholar
PubMed
Search for other papers by R Webb in
Google Scholar
PubMed
Search for other papers by A Weisbrod in
Google Scholar
PubMed
Search for other papers by B Bian in
Google Scholar
PubMed
Search for other papers by M He in
Google Scholar
PubMed
Search for other papers by L Zhang in
Google Scholar
PubMed
Search for other papers by A K Holloway in
Google Scholar
PubMed
Search for other papers by R Krishna in
Google Scholar
PubMed
Search for other papers by N Nilubol in
Google Scholar
PubMed
Search for other papers by K Pacak in
Google Scholar
PubMed
Search for other papers by E Kebebew in
Google Scholar
PubMed
( Zarnegar et al . 2006 ). The prevalence of malignant pheochromocytoma is 2.5–40%, and the overall survival rate is <50% at 5 years ( Zarnegar et al . 2006 ). Currently, there are no reliable histologic or molecular markers for distinguishing between
Search for other papers by Vincenzo Marotta in
Google Scholar
PubMed
Search for other papers by Maria Chiara Zatelli in
Google Scholar
PubMed
Search for other papers by Concetta Sciammarella in
Google Scholar
PubMed
Search for other papers by Maria Rosaria Ambrosio in
Google Scholar
PubMed
Search for other papers by Marta Bondanelli in
Google Scholar
PubMed
Search for other papers by Annamaria Colao in
Google Scholar
PubMed
Search for other papers by Antongiulio Faggiano in
Google Scholar
PubMed
. Particularly, researchers aimed to identify markers useful for (a) diagnosis anticipation and refining, (b) prognostic stratification and (c) disease evolution monitoring and response to treatment. Based on the relationship with codified hormone
Department of Clinical Medical Sciences, Seoul National University, College of Medicine, Seoul, Republic of Korea
Search for other papers by Kwon Joong Na in
Google Scholar
PubMed
Cheonan Public Health Center, Chungnam, Republic of Korea
Search for other papers by Hongyoon Choi in
Google Scholar
PubMed
’s multiple testing corrections. Expression of immunosuppressive molecular markers, CTLA-4, PD-L1 and HLA-G, was statistically compared according to TDS and the BRAF V600E mutation status. The correlation between TDS and immunosuppressive markers was
Search for other papers by Chun-Peng Liao in
Google Scholar
PubMed
Search for other papers by Leng-Ying Chen in
Google Scholar
PubMed
Search for other papers by Andrea Luethy in
Google Scholar
PubMed
Search for other papers by Youngsoo Kim in
Google Scholar
PubMed
Search for other papers by Kian Kani in
Google Scholar
PubMed
Search for other papers by A Robert MacLeod in
Google Scholar
PubMed
Search for other papers by Mitchell E Gross in
Google Scholar
PubMed
attenuated by co-incubation with AR-depleted CAFs. Interestingly, the expression of several stem cell marker genes was upregulated in PCa cells grown with AR-depleted CAFs. Further, interferon gamma (IFN-γ) and macrophage colony-stimulating factor (M
Search for other papers by Maria Chiara Zatelli in
Google Scholar
PubMed
Search for other papers by Giuseppe Fanciulli in
Google Scholar
PubMed
Search for other papers by Pasqualino Malandrino in
Google Scholar
PubMed
Search for other papers by Valeria Ramundo in
Google Scholar
PubMed
Search for other papers by Antongiulio Faggiano in
Google Scholar
PubMed
Search for other papers by Annamaria Colao in
Google Scholar
PubMed
Search for other papers by on behalf of NIKE Group in
Google Scholar
PubMed
enteropancreatic neuroendocrine tumors . Anticancer Research 30 5063 – 5067 . Gilbert JA Adhikari LJ Lloyd RV Halfdanarson TR Muders MH Ames MM 2013 Molecular markers for novel therapeutic strategies in pancreatic endocrine tumors . Pancreas
Search for other papers by Mojun Zhu in
Google Scholar
PubMed
Search for other papers by Karl R Sorenson in
Google Scholar
PubMed
Search for other papers by Rebecca Liu in
Google Scholar
PubMed
Search for other papers by Bonnie E Gould Rothberg in
Google Scholar
PubMed
Search for other papers by Thorvardur R Halfdanarson in
Google Scholar
PubMed
Search strategy We searched the PubMed database through February 1, 2021, in order to identify primary research articles that analyzed molecular markers as PNET prognostic factors. A non-redundant list of candidate articles was created from the union of
Search for other papers by Ta-Chun Yuan in
Google Scholar
PubMed
Search for other papers by Suresh Veeramani in
Google Scholar
PubMed
Search for other papers by Fen-Fen Lin in
Google Scholar
PubMed
Search for other papers by Dmitry Kondrikou in
Google Scholar
PubMed
Search for other papers by Stanislav Zelivianski in
Google Scholar
PubMed
Search for other papers by Tsukasa Igawa in
Google Scholar
PubMed
Search for other papers by Dev Karan in
Google Scholar
PubMed
Search for other papers by Surinder K. Batra in
Google Scholar
PubMed
Search for other papers by Ming-Fong Lin in
Google Scholar
PubMed
cytoplasm and secrete several neuronal markers as well as growth-stimulatory factors, while they lack the expression of androgen receptor (AR). It is proposed that these NE cells originate from endodermal epithelial cells and are terminally differentiated
Search for other papers by Hen Prizant in
Google Scholar
PubMed
Search for other papers by Manisha Taya in
Google Scholar
PubMed
Search for other papers by Irina Lerman in
Google Scholar
PubMed
Search for other papers by Allison Light in
Google Scholar
PubMed
Search for other papers by Aritro Sen in
Google Scholar
PubMed
Search for other papers by Soumya Mitra in
Google Scholar
PubMed
Search for other papers by Thomas H Foster in
Google Scholar
PubMed
Search for other papers by Stephen R Hammes in
Google Scholar
PubMed
TSC2 mutations, LAM cells typically express melanocytic markers. One such marker, gp100 (PMEL), is often up-regulated in LAM cells ( Kuhnen et al . 2001 ). PMEL is the target for the HMB-45 antibody; thus, HMB-45 staining by immunohistochemistry (IHC
Department of Hematology and Oncology, Emory University School of Medicine, Atlanta, Georgia, USA
Search for other papers by Jennifer W Carlisle in
Google Scholar
PubMed
Department of Urology, Emory University School of Medicine, Atlanta, Georgia, USA
Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA
Search for other papers by Caroline S Jansen in
Google Scholar
PubMed
Department of Hematology and Oncology, Emory University School of Medicine, Atlanta, Georgia, USA
Search for other papers by Mehmet Asim Bilen in
Google Scholar
PubMed
Department of Urology, Emory University School of Medicine, Atlanta, Georgia, USA
Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA
Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA
Search for other papers by Haydn Kissick in
Google Scholar
PubMed
considered. Herein, we review the T-cell response to acute viral infection, explore the overlap among markers of T-cell activation in response to immunotherapy and in viral infections, highlight similarities in systemic inflammatory profiles in these two
Search for other papers by Y M H Jonkers in
Google Scholar
PubMed
Search for other papers by S M H Claessen in
Google Scholar
PubMed
Search for other papers by A Perren in
Google Scholar
PubMed
Search for other papers by A M Schmitt in
Google Scholar
PubMed
Search for other papers by L J Hofland in
Google Scholar
PubMed
Search for other papers by W de Herder in
Google Scholar
PubMed
Search for other papers by R R de Krijger in
Google Scholar
PubMed
Search for other papers by A A J Verhofstad in
Google Scholar
PubMed
Search for other papers by A R Hermus in
Google Scholar
PubMed
Search for other papers by J A Kummer in
Google Scholar
PubMed
Search for other papers by B Skogseid in
Google Scholar
PubMed
Search for other papers by M Volante in
Google Scholar
PubMed
Search for other papers by A C Voogd in
Google Scholar
PubMed
Search for other papers by F C S Ramaekers in
Google Scholar
PubMed
Search for other papers by E J M Speel in
Google Scholar
PubMed
is also expressed in benign tumors, this marker is considered to be of limited value ( Heitz et al. 1987 , Graeme-Cook et al. 1990 ). Up-regulation of COX2 and CK19, and down-regulation of p27 and CD99 were found to be associated with Ki67